Novo Nordisk or Eli Lilly? The Billion-Dollar GLP-1 Battle Is Heating Up
The global pharmaceutical industry is witnessing one of the biggest healthcare competitions in history. Two industry giants—Novo Nordisk and Eli Lilly—are …
FDA News
FDA Approves Historic Gene Therapy for Children—A New Milestone in Modern Medicine
The U.S. Food and Drug Administration (FDA) has approved the first gene therapy for young children with sickle cell disease, marking …
AI Is Revolutionizing Drug Discovery—Here’s Why Big Pharma Is Investing Billions
Artificial Intelligence (AI) is no longer just a buzzword in the technology sector—it has become one of the most important forces …
Eli Lilly Expands U.S. Manufacturing in 2026: What It Means for GLP-1 Drugs, Pharma Jobs, and Healthcare Innovation
The demand for GLP-1 medicines used in diabetes care and, where approved, chronic weight management has grown rapidly in recent years. …
$10 Billion Pharma Deal Could Transform Rare Disease Treatments
The pharmaceutical industry has witnessed another major acquisition as Vertex Pharmaceuticals announced an agreement to acquire Crinetics Pharmaceuticals in a transaction …
Generic GLP-1 Drugs Could Change the Weight-Loss Market—FDA Begins Review
The U.S. market for GLP-1 medicines continues to expand rapidly as demand for obesity and diabetes treatments grows. In another important …
FDA Approves Sanofi’s Wearable Cancer Drug Device—A Big Step for Cancer Care
The U.S. Food and Drug Administration (FDA) has approved a wearable injector version of Sanofi’s blood cancer medicine Sarclisa for eligible …
FDA Plans to Simplify Drug Manufacturer Registration—Here’s Why It Matters
The U.S. Food and Drug Administration (FDA) has proposed a new rule that could simplify registration requirements for certain drug manufacturers …
Dr. Reddy’s Semaglutide Supply Delay: What It Means for the Global GLP-1 Market in 2026
The global race to expand access to GLP-1 medicines has reached another important milestone after Dr. Reddy’s Laboratories announced a temporary …